Master in Triple Negative Breast Cancer

Triple-Negative Breast Cancer (r)evolution focuses on the complexities of this specific breast cancer form, which lacks expression of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). The program is ideal for researchers, clinicians, and healthcare professionals eager to advance their understanding and treatment of Triple-Negative Breast Cancer. The course features interdisciplinary modules, drawing on the latest scientific research and clinical best practices. Students will also gain insights from the European School of Oncology, which is associated with the course.

The curriculum includes modules such as 'Breast Cancer: Triple Negative Breast Cancer' and 'Advanced Breast Cancer Research'.